Brown Advisory’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $139K | Hold |
60,777
| – | – | ﹤0.01% | 1355 |
|
|
2025
Q4 | $243K | Hold |
60,777
| – | – | ﹤0.01% | 1281 |
|
|
2025
Q3 | $514K | Buy |
60,777
+18,749
| +45% | +$182K | ﹤0.01% | 1034 |
|
|
2025
Q2 | $473K | Hold |
42,028
| – | – | ﹤0.01% | 1031 |
|
|
2025
Q1 | $398K | Buy |
42,028
+80
| +0.2% | +$808 | ﹤0.01% | 1053 |
|
|
2024
Q4 | $472K | Buy |
41,948
+2
| +0% | +$35 | ﹤0.01% | 1031 |
|
|
2024
Q3 | $1.19M | Buy |
41,946
+27
| +0.1% | +$696 | ﹤0.01% | 749 |
|
|
2024
Q2 | $801K | Buy |
41,919
+5,049
| +14% | +$129K | ﹤0.01% | 822 |
|
|
2024
Q1 | $1.21M | Hold |
36,870
| – | – | ﹤0.01% | 737 |
|
|
2023
Q4 | $1.22M | Hold |
36,870
| – | – | ﹤0.01% | 725 |
|
|
2023
Q3 | $1M | Buy |
36,870
+5,564
| +18% | +$155K | ﹤0.01% | 741 |
|
|
2023
Q2 | $949K | Hold |
31,306
| – | – | ﹤0.01% | 761 |
|
|
2023
Q1 | $1.02M | Hold |
31,306
| – | – | ﹤0.01% | 755 |
|
|
2022
Q4 | $879K | Hold |
31,306
| – | – | ﹤0.01% | 781 |
|
|
2022
Q3 | $1.13M | Buy |
31,306
+7,785
| +33% | +$274K | ﹤0.01% | 686 |
|
|
2022
Q2 | $722K | Hold |
23,521
| – | – | ﹤0.01% | 763 |
|
|
2022
Q1 | $760K | Hold |
23,521
| – | – | ﹤0.01% | 765 |
|
|
2021
Q4 | $651K | Buy |
+23,521
| New | +$675K | ﹤0.01% | 816 |
|
|
2020
Q3 | – | Sell |
-20,138
| Closed | -$143K | – | 980 |
|
|
2020
Q2 | $143K | Hold |
20,138
| – | – | ﹤0.01% | 907 |
|
|
2020
Q1 | $109K | Sell |
20,138
-10,713
| -35% | -$95.7K | ﹤0.01% | 899 |
|
|
2019
Q4 | $279K | Hold |
30,851
| – | – | ﹤0.01% | 900 |
|
|
2019
Q3 | $222K | Buy |
30,851
+20,731
| +205% | +$149K | ﹤0.01% | 924 |
|
|
2019
Q2 | $80K | Buy |
10,120
+120
| +1% | +$1.42K | ﹤0.01% | 1005 |
|
|
2019
Q1 | $126K | Hold |
10,000
| – | – | ﹤0.01% | 1276 |
|
|
2018
Q4 | $199K | Hold |
10,000
| – | – | ﹤0.01% | 1182 |
|
|
2018
Q3 | $284K | Hold |
10,000
| – | – | ﹤0.01% | 1169 |
|
|
2018
Q2 | $210K | Buy |
+10,000
| New | +$189K | ﹤0.01% | 1209 |
|
|
2017
Q2 | – | Sell |
-25,000
| Closed | -$557K | – | 1227 |
|
|
2017
Q1 | $557K | Hold |
25,000
| – | – | ﹤0.01% | 781 |
|
|
2016
Q4 | $370K | Hold |
25,000
| – | – | ﹤0.01% | 868 |
|
|
2016
Q3 | $615K | Buy |
+25,000
| New | +$584K | ﹤0.01% | 711 |
|
|
2016
Q2 | – | Sell |
-50,000
| Closed | -$528K | – | 1061 |
|
|
2016
Q1 | $528K | Hold |
50,000
| – | – | ﹤0.01% | 703 |
|
|
2015
Q4 | $605K | Buy |
+50,000
| New | +$737K | ﹤0.01% | 648 |
|
Other funds holding EVH
CCM
RF
EC
VCM
RSCM
Brown Advisory's EVH Position: Q1 2026 in Review
Brown Advisory held its Evolent Health (EVH) position steady in Q1 2026 at 60,777 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #1355.
Brown Advisory first reported a position in EVH in Q4 2015 and has held it in 32 quarters since. The position peaked at $1.22M in Q4 2023. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.
- Brown Advisory held 60,777 shares of Evolent Health worth $139K as of Q1 2026.
- Brown Advisory left its Evolent Health share count unchanged in Q1 2026.
- Evolent Health made up ﹤0.01% of Brown Advisory's portfolio in Q1 2026, its #1355 holding.
- Brown Advisory first reported a position in Evolent Health in Q4 2015 and has held it in 32 quarters since.
- Brown Advisory's Evolent Health position peaked at $1.22M in Q4 2023.
- 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.
Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.